688626 翔宇医疗
交易中 11-06 14:17:15
资讯
新帖
简况
翔宇医疗新注册《肌电生物反馈训练系统V1》项目的软件著作权
证券之星 · 11-05 05:42
翔宇医疗新注册《肌电生物反馈训练系统V1》项目的软件著作权
翔宇医疗(688626)11月2日主力资金净卖出1144.24万元
证券之星 · 11-03
翔宇医疗(688626)11月2日主力资金净卖出1144.24万元
翔宇医疗获得发明专利授权:“一种骨盆训练器的同步反向运动装置”
证券之星 · 11-02
翔宇医疗获得发明专利授权:“一种骨盆训练器的同步反向运动装置”
翔宇医疗(688626)2026年三季报简析:营收净利润同比双双增长,存货明显上升
证券之星 · 10-31
翔宇医疗(688626)2026年三季报简析:营收净利润同比双双增长,存货明显上升
翔宇医疗获得外观设计专利授权:“微波治疗机”
证券之星 · 10-31
翔宇医疗获得外观设计专利授权:“微波治疗机”
股市必读:翔宇医疗新发布《翔宇医疗关于召开2026年第三季度业绩说明会的公告》
证券之星 · 10-30
股市必读:翔宇医疗新发布《翔宇医疗关于召开2026年第三季度业绩说明会的公告》
图解翔宇医疗三季报:第三季度单季净利润同比下降39.26%
证券之星 · 10-30
图解翔宇医疗三季报:第三季度单季净利润同比下降39.26%
10月20日翔宇医疗涨13.32%,创金合信大健康混合A基金重仓该股
证券之星 · 10-20
10月20日翔宇医疗涨13.32%,创金合信大健康混合A基金重仓该股
股市必读:翔宇医疗新发布《翔宇医疗关于为全资子公司提供担保的进展公告》
证券之星 · 10-08
股市必读:翔宇医疗新发布《翔宇医疗关于为全资子公司提供担保的进展公告》
股市必读:翔宇医疗新发布《翔宇医疗关于为全资子公司提供担保的进展公告》
证券之星 · 09-30
股市必读:翔宇医疗新发布《翔宇医疗关于为全资子公司提供担保的进展公告》
股市必读:翔宇医疗(688626)9月22日董秘有最新回复
证券之星 · 09-23
股市必读:翔宇医疗(688626)9月22日董秘有最新回复
9月22日翔宇医疗涨6.59%,创金合信大健康混合A基金重仓该股
证券之星 · 09-22
9月22日翔宇医疗涨6.59%,创金合信大健康混合A基金重仓该股
翔宇医疗获得发明专利授权:“一种动态平衡训练方法及系统”
证券之星 · 09-11
翔宇医疗获得发明专利授权:“一种动态平衡训练方法及系统”
翔宇医疗获得实用新型专利授权:“一种基于双轴云台结构的无接触式监测仪”
证券之星 · 09-11
翔宇医疗获得实用新型专利授权:“一种基于双轴云台结构的无接触式监测仪”
翔宇医疗新注册《脑机接口上肢康复训练系统V1》等2个项目的软件著作权
证券之星 · 09-05
翔宇医疗新注册《脑机接口上肢康复训练系统V1》等2个项目的软件著作权
股市必读:翔宇医疗(688626)9月3日董秘有最新回复
证券之星 · 09-04
股市必读:翔宇医疗(688626)9月3日董秘有最新回复
翔宇医疗(688626)披露修订《公司章程》及部分治理制度公告,8月31日股价上涨0.94%
证券之星 · 08-31
翔宇医疗(688626)披露修订《公司章程》及部分治理制度公告,8月31日股价上涨0.94%
每周股票复盘:翔宇医疗(688626)Q2净利增15.19%
证券之星 · 08-30
每周股票复盘:翔宇医疗(688626)Q2净利增15.19%
翔宇医疗(688626)2026年中报简析:营收净利润同比双双增长,公司应收账款体量较大
证券之星 · 08-30
翔宇医疗(688626)2026年中报简析:营收净利润同比双双增长,公司应收账款体量较大
图解翔宇医疗中报:第二季度单季净利润同比增长15.19%
证券之星 · 08-29
图解翔宇医疗中报:第二季度单季净利润同比增长15.19%
加载更多
公司概况
公司名称:
河南翔宇医疗设备股份有限公司
所属行业:
专用设备制造业
上市日期:
2021-03-31
主营业务:
河南翔宇医疗设备股份有限公司的主营业务是康复医疗器械研发、生产、销售和服务。公司的主要产品是康复理疗设备类、康复训练设备类、康复评定设备类、配件产品。作为国家级高新技术企业,翔宇医疗被国家中医药管理局认定为中医诊疗设备生产示范基地,被工信部认定为国家首批专精特新“小巨人”企业、获评体育领域国家级专精特新“小巨人”企业,被国家知识产权局评为国家知识产权示范企业,荣获河南省省长质量奖,翔宇医疗商标被国家工商行政管理总局评为中国驰名商标。
发行价格:
28.82
{"stockData":{"symbol":"688626","market":"SH","secType":"STK","nameCN":"翔宇医疗","latestPrice":40.49,"timestamp":1793945835000,"preClose":41.57,"halted":0,"volume":2353732,"delay":0,"changeRate":-0.026,"floatShares":160000000,"shares":160000000,"eps":0.4941,"marketStatus":"交易中","change":-1.08,"latestTime":"11-06 14:17:15","open":39.67,"high":41.99,"low":39.67,"amount":96329900,"amplitude":0.0558,"askPrice":40.49,"askSize":2,"bidPrice":40.48,"bidSize":8,"shortable":0,"etf":0,"ttmEps":0.4941,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1793948400000},"marketStatusCode":2,"adr":0,"adjPreClose":41.57,"symbolType":"stock_kcb","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":45.73,"lowLimit":37.41,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":160000000,"isCdr":false,"pbRate":3.08,"roa":"--","peRate":81.946974,"roe":"2.14%","epsLYR":0.51,"committee":0.223881,"marketValue":6478000000,"turnoverRate":0.0147,"status":1,"floatMarketCap":6478000000},"requestUrl":"/m/hq/s/688626","defaultTab":"news","newsList":[{"id":"2681373095","title":"翔宇医疗新注册《肌电生物反馈训练系统V1》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2681373095","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681373095?lang=zh_cn&edition=full","pubTime":"2026-11-05 05:42","pubTimestamp":1793828541,"startTime":"0","endTime":"0","summary":"证券之星消息,近日翔宇医疗(688626)新注册了《肌电生物反馈训练系统V1》项目的软件著作权。今年以来翔宇医疗新注册软件著作权23个。结合公司2026年中报财务数据,今年上半年公司在研发方面投入了7908.01万元,同比减6.12%。通过天眼查大数据分析,河南翔宇医疗设备股份有限公司共对外投资了46家企业,参与招投标项目3211次;财产线索方面有商标信息155条,专利信息2682条,著作权信息125条;此外企业还拥有行政许可664个。数据来源:企查查以上内容为证券之星据公开信息整理,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500006618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","159180","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680797898","title":"翔宇医疗(688626)11月2日主力资金净卖出1144.24万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680797898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680797898?lang=zh_cn&edition=full","pubTime":"2026-11-03 08:48","pubTimestamp":1793666907,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月2日收盘,翔宇医疗报收于39.83元,下跌0.6%,换手率3.36%,成交量5.38万手,成交额2.07亿元。近5日资金流向一览见下表:翔宇医疗融资融券信息显示,融资方面,当日融资买入2190.11万元,融资偿还2240.89万元,融资净偿还50.78万元。翔宇医疗主营业务:康复医疗器械的研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300010718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680200865","title":"翔宇医疗获得发明专利授权:“一种骨盆训练器的同步反向运动装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2680200865","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680200865?lang=zh_cn&edition=full","pubTime":"2026-11-02 03:59","pubTimestamp":1793563187,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示翔宇医疗新获得一项发明专利授权,专利名为“一种骨盆训练器的同步反向运动装置”,专利申请号为CN202310234988.7,授权日为2026年10月30日。今年以来翔宇医疗新获得专利授权220个,较去年同期增加了16.4%。通过天眼查大数据分析,河南翔宇医疗设备股份有限公司共对外投资了46家企业,参与招投标项目3211次;财产线索方面有商标信息155条,专利信息2682条,著作权信息125条;此外企业还拥有行政许可664个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200001190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679222815","title":"翔宇医疗(688626)2026年三季报简析:营收净利润同比双双增长,存货明显上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2679222815","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679222815?lang=zh_cn&edition=full","pubTime":"2026-10-31 11:36","pubTimestamp":1793417816,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期翔宇医疗发布2026年三季报。截至本报告期末,公司营业总收入5.39亿元,同比上升0.33%,归母净利润4487.21万元,同比上升2.02%。按单季度数据看,第三季度营业总收入1.66亿元,同比下降6.95%,第三季度归母净利润521.59万元,同比下降39.26%。本报告期翔宇医疗存货明显上升,存货同比增幅达42.17%。持有翔宇医疗最多的基金为中银健康生活混合A,目前规模为0.6亿元,最新净值1.6441,较上一交易日下跌0.66%,近一年上涨21.69%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100024664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679141223","title":"翔宇医疗获得外观设计专利授权:“微波治疗机”","url":"https://stock-news.laohu8.com/highlight/detail?id=2679141223","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679141223?lang=zh_cn&edition=full","pubTime":"2026-10-31 06:27","pubTimestamp":1793399254,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示翔宇医疗新获得一项外观设计专利授权,专利名为“微波治疗机”,专利申请号为CN202630219560.X,授权日为2026年10月30日。今年以来翔宇医疗新获得专利授权216个,较去年同期增加了14.29%。通过天眼查大数据分析,河南翔宇医疗设备股份有限公司共对外投资了46家企业,参与招投标项目3211次;财产线索方面有商标信息155条,专利信息2682条,著作权信息125条;此外企业还拥有行政许可664个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100012078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679301237","title":"股市必读:翔宇医疗新发布《翔宇医疗关于召开2026年第三季度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2679301237","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679301237?lang=zh_cn&edition=full","pubTime":"2026-10-30 05:48","pubTimestamp":1793310513,"startTime":"0","endTime":"0","summary":"截至2026年10月29日收盘,翔宇医疗报收于41.05元,下跌3.34%,换手率1.58%,成交量2.53万手,成交额1.06亿元。股本股东变化:截至2026年9月30日股东户数为1.41万户,较6月30日增长10.3%。公司公告汇总:公司将于2026年11月9日召开2026年第三季度业绩说明会;同日董事会审议通过增加2026年度日常关联交易预计500.00万元,全部为向杭州北康医院有限公司销售产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000008983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679333962","title":"图解翔宇医疗三季报:第三季度单季净利润同比下降39.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679333962","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679333962?lang=zh_cn&edition=full","pubTime":"2026-10-30 03:28","pubTimestamp":1793302083,"startTime":"0","endTime":"0","summary":"证券之星消息,翔宇医疗2026年三季报显示,前三季度公司主营收入5.39亿元,同比上升0.33%;归母净利润4487.21万元,同比上升2.02%;扣非净利润3106.18万元,同比上升3.75%;其中2026年第三季度,公司单季度主营收入1.66亿元,同比下降6.95%;单季度归母净利润521.59万元,同比下降39.26%;单季度扣非净利润213.31万元,同比下降69.11%;负债率29.06%,投资收益538.45万元,财务费用-801.36万元,毛利率67.84%。财报数据概要请见下图:本文数据来源于翔宇医疗2026年三季报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000005789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676665650","title":"10月20日翔宇医疗涨13.32%,创金合信大健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676665650","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676665650?lang=zh_cn&edition=full","pubTime":"2026-10-20 16:29","pubTimestamp":1792484964,"startTime":"0","endTime":"0","summary":"证券之星消息,10月20日翔宇医疗涨13.32%,收盘报41.08元,换手率4.61%,成交量7.37万手,成交额2.99亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共3家,其中持有数量最多的公募基金为创金合信基金的创金合信大健康混合A。创金合信大健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000024489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673171320","title":"股市必读:翔宇医疗新发布《翔宇医疗关于为全资子公司提供担保的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673171320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673171320?lang=zh_cn&edition=full","pubTime":"2026-10-08 03:09","pubTimestamp":1791400150,"startTime":"0","endTime":"0","summary":"公司公告汇总:翔宇医疗为全资子公司瑞贝塔提供不超过15,100.00万元连带责任担保,该担保在董事会已批准的40,000.00万元额度内,公司对外担保总额25,100.00万元,占最近一期经审计净资产的12.13%。公司公告汇总翔宇医疗关于为全资子公司提供担保的进展公告河南翔宇医疗设备股份有限公司为全资子公司河南瑞贝塔医疗科技有限公司向中国进出口银行河南省分行申请的不超过15,100.00万元贷款提供连带责任担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671440962","title":"股市必读:翔宇医疗新发布《翔宇医疗关于为全资子公司提供担保的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671440962","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671440962?lang=zh_cn&edition=full","pubTime":"2026-09-30 03:24","pubTimestamp":1790709855,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘,翔宇医疗报收于42.05元,下跌0.64%,换手率1.01%,成交量1.61万手,成交额6847.41万元。公司公告汇总翔宇医疗关于为全资子公司提供担保的进展公告河南翔宇医疗设备股份有限公司为全资子公司河南瑞贝塔医疗科技有限公司向中国进出口银行河南省分行申请的不超过15,100.00万元贷款提供连带责任担保。截至公告日,公司及控股子公司对外担保总额为25,100.00万元,占公司最近一期经审计净资产的12.13%,无逾期担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000003055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669129594","title":"股市必读:翔宇医疗(688626)9月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2669129594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669129594?lang=zh_cn&edition=full","pubTime":"2026-09-23 01:35","pubTimestamp":1790098512,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘,翔宇医疗报收于44.0元,上涨6.59%,换手率3.9%,成交量6.24万手,成交额2.7亿元。董秘最新回复投资者: 亲爱的董秘您好!公司将立足主业、完善经营,实现公司高质量发展,积极做好投资者回报,感谢您对公司的关注和支持。当日关注点交易信息汇总:9月22日主力资金净流入959.16万元,占总成交额3.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669171601","title":"9月22日翔宇医疗涨6.59%,创金合信大健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669171601","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669171601?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:39","pubTimestamp":1790066372,"startTime":"0","endTime":"0","summary":"证券之星消息,9月22日翔宇医疗涨6.59%,收盘报44.0元,换手率3.9%,成交量6.24万手,成交额2.7亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共3家,其中持有数量最多的公募基金为创金合信基金的创金合信大健康混合A。创金合信大健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200028627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666086518","title":"翔宇医疗获得发明专利授权:“一种动态平衡训练方法及系统”","url":"https://stock-news.laohu8.com/highlight/detail?id=2666086518","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666086518?lang=zh_cn&edition=full","pubTime":"2026-09-11 03:29","pubTimestamp":1789068599,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示翔宇医疗新获得一项发明专利授权,专利名为“一种动态平衡训练方法及系统”,专利申请号为CN202411309729.7,授权日为2026年8月28日。今年以来翔宇医疗新获得专利授权193个,较去年同期增加了8.43%。通过天眼查大数据分析,河南翔宇医疗设备股份有限公司共对外投资了45家企业,参与招投标项目3041次;财产线索方面有商标信息155条,专利信息2632条,著作权信息123条;此外企业还拥有行政许可658个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100005416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666451824","title":"翔宇医疗获得实用新型专利授权:“一种基于双轴云台结构的无接触式监测仪”","url":"https://stock-news.laohu8.com/highlight/detail?id=2666451824","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666451824?lang=zh_cn&edition=full","pubTime":"2026-09-11 03:27","pubTimestamp":1789068456,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示翔宇医疗新获得一项实用新型专利授权,专利名为“一种基于双轴云台结构的无接触式监测仪”,专利申请号为CN202520908307.5,授权日为2026年8月28日。本装置可实现摄像头跟踪人脸的效果,实现无接触式的生命体征监测。今年以来翔宇医疗新获得专利授权193个,较去年同期增加了8.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100004823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665518356","title":"翔宇医疗新注册《脑机接口上肢康复训练系统V1》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2665518356","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665518356?lang=zh_cn&edition=full","pubTime":"2026-09-05 02:20","pubTimestamp":1788546020,"startTime":"0","endTime":"0","summary":"证券之星消息,近日翔宇医疗(688626)新注册了2个项目的软件著作权,包括《脑机接口上肢康复训练系统V1》、《脑机交互康复训练系统V1》等。今年以来翔宇医疗新注册软件著作权22个,较去年同期增加了10%。结合公司2026年中报财务数据,今年上半年公司在研发方面投入了7908.01万元,同比减6.12%。通过天眼查大数据分析,河南翔宇医疗设备股份有限公司共对外投资了45家企业,参与招投标项目3041次;财产线索方面有商标信息155条,专利信息2632条,著作权信息123条;此外企业还拥有行政许可658个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090500000184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664280523","title":"股市必读:翔宇医疗(688626)9月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2664280523","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664280523?lang=zh_cn&edition=full","pubTime":"2026-09-04 01:20","pubTimestamp":1788456023,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘,翔宇医疗报收于40.54元,下跌0.83%,换手率0.81%,成交量1.29万手,成交额5239.0万元。这些上市的医疗器械是否与2025年已获批的两项脑电器械共同构成非侵入脑机接口医疗器械?董秘: 尊敬的投资者您好,2026年上半年,公司新增医疗器械注册证/备案凭证34项,包括多款非侵入式脑电诱发设备的医疗器械注册证。当日关注点交易信息汇总:9月3日主力资金净流出593.54万元,占总成交额11.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400001904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663074034","title":"翔宇医疗(688626)披露修订《公司章程》及部分治理制度公告,8月31日股价上涨0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074034","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663074034?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:27","pubTimestamp":1788172032,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,翔宇医疗报收于43.06元,较前一交易日上涨0.94%,最新总市值为68.9亿元。公司于近日披露《关于修订〈公司章程〉及部分治理制度的公告》。公告显示,河南翔宇医疗设备股份有限公司于2026年8月27日召开第三届董事会第十三次会议,审议通过《关于修订〈公司章程〉的议案》和《关于修订〈董事、高级管理人员薪酬管理制度〉的议案》。修订后的《公司章程》及相关制度全文已披露于上海证券交易所网站。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100027876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663804302","title":"每周股票复盘:翔宇医疗(688626)Q2净利增15.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663804302","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663804302?lang=zh_cn&edition=full","pubTime":"2026-08-30 08:48","pubTimestamp":1788050891,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,翔宇医疗报收于42.66元,较上周的43.7元下跌2.38%。本周,翔宇医疗8月24日盘中最高价报43.84元。来自公司公告汇总:翔宇医疗拟为参股公司提供不超过825万元反担保,尚需股东会审议。股本股东变化截至2026年6月30日,翔宇医疗股东户数为1.27万户,较3月31日减少957户,减幅6.98%。业绩披露要点翔宇医疗2026年中报显示,上半年主营收入3.73亿元,同比上升3.93%;归母净利润3965.62万元,同比上升12.04%;扣非净利润2892.88万元,同比上升25.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663048147","title":"翔宇医疗(688626)2026年中报简析:营收净利润同比双双增长,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2663048147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663048147?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:18","pubTimestamp":1788041893,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期翔宇医疗发布2026年中报。截至本报告期末,公司营业总收入3.73亿元,同比上升3.93%,归母净利润3965.62万元,同比上升12.04%。本报告期翔宇医疗公司应收账款体量较大,当期应收账款占最新年报归母净利润比达101.52%。答:2025年,公司研发投入占营业总收入的比例达到24.65%,位居国内医疗器械上市公司前列。本文数据来源于翔宇医疗2026年中报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000002428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663189410","title":"图解翔宇医疗中报:第二季度单季净利润同比增长15.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663189410","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663189410?lang=zh_cn&edition=full","pubTime":"2026-08-29 02:09","pubTimestamp":1787940546,"startTime":"0","endTime":"0","summary":"证券之星消息,翔宇医疗2026年中报显示,上半年度公司主营收入3.73亿元,同比上升3.93%;归母净利润3965.62万元,同比上升12.04%;扣非净利润2892.88万元,同比上升25.59%;其中2026年第二季度,公司单季度主营收入1.8亿元,同比上升4.1%;单季度归母净利润1433.42万元,同比上升15.19%;单季度扣非净利润563.57万元,同比上升30.29%;负债率35.96%,投资收益627.97万元,财务费用-510.07万元,毛利率67.63%。财报数据概要请见下图:本文数据来源于翔宇医疗2026年中报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900005920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793945847824,"stockEarnings":[{"period":"1week","weight":0.0127},{"period":"1month","weight":-0.0091},{"period":"3month","weight":-0.1099},{"period":"6month","weight":-0.3271},{"period":"1year","weight":-0.2084},{"period":"ytd","weight":-0.3104}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0396},{"period":"3month","weight":-0.0635},{"period":"6month","weight":-0.1172},{"period":"1year","weight":-0.0704},{"period":"ytd","weight":-0.0703}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"河南翔宇医疗设备股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"14061人(较上一季度增加10.30%)","perCapita":"11378股","listingDate":"2021-03-31","address":"河南省安阳市内黄县帝喾大道中段","registeredCapital":"16000万元","survey":" 河南翔宇医疗设备股份有限公司的主营业务是康复医疗器械研发、生产、销售和服务。公司的主要产品是康复理疗设备类、康复训练设备类、康复评定设备类、配件产品。作为国家级高新技术企业,翔宇医疗被国家中医药管理局认定为中医诊疗设备生产示范基地,被工信部认定为国家首批专精特新“小巨人”企业、获评体育领域国家级专精特新“小巨人”企业,被国家知识产权局评为国家知识产权示范企业,荣获河南省省长质量奖,翔宇医疗商标被国家工商行政管理总局评为中国驰名商标。","listedPrice":28.82},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翔宇医疗(688626)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翔宇医疗(688626)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翔宇医疗,688626,翔宇医疗股票,翔宇医疗股票老虎,翔宇医疗股票老虎国际,翔宇医疗行情,翔宇医疗股票行情,翔宇医疗股价,翔宇医疗股市,翔宇医疗股票价格,翔宇医疗股票交易,翔宇医疗股票购买,翔宇医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翔宇医疗(688626)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翔宇医疗(688626)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}